Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ACTU · NASDAQ · Pharmaceutical Preparations
$0.2253+0.0115 (+5.38%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Actuate Therapeutics (ACTU) · oqro.io/stocks/ACTU · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Oct 27, 2026 · Filed Oct 30, 2026
Hexstone Capital LLC now owns 7.7% of ACTU as a passive investorSourceInsider trade · Traded Oct 28, 2026 · Filed Oct 29, 2026
CEO purchased ~$50K of ACTU shares in the open marketSourceInsider trade · Traded Jan 5, 2026 · Filed Jan 7, 2026
Director sold ~$1.62M of ACTU shares in the open marketSourceInsider trade · Traded Jun 27, 2025 · Filed Jun 30, 2025
Director purchased ~$500K of ACTU shares in the open marketSourceInsider trade · Traded Jun 27, 2025 · Filed Jun 30, 2025
Director purchased ~$500K of ACTU shares in the open marketSourceInsider trade · Traded Jun 27, 2025 · Filed Jun 30, 2025
Director purchased ~$500K of ACTU shares in the open marketSource